Press Releases

GlobeNewswire, Inc.

TAMPA, Fla. and LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced the grant of...

GlobeNewswire, Inc.

Data will reflect the functional characterization of EVX-04 Poster presentation on June 13, 2026 COPENHAGEN, Denmark, May 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its...

GlobeNewswire, Inc.

FREDERICK, Md., March 25, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that its Binary Ionization Technology has received...

GlobeNewswire, Inc.

Pooled analyses in patients with moderate Alzheimer’s show dose-related cognitive benefit and signs of durability. 100% of patients remained stable or improved, with 50% improving from moderate to mild cognitive function.

EIN Presswire

Since 2019, the Job Research Foundation has supported 17 scientific research projects worldwide investigating the rare disorder known as Job Syndrome.

EIN Presswire

The Hearing Aids Market was valued at USD 9.53 billion in 2025 and is projected to reach USD 14.53 billion by 2032, growing at a CAGR of 6.2%. ROCKVILLE , MD, UNITED STATES, March 25, 2026 /⁨EINPresswire.com⁩/ -- Maximize Market Research, the...

GlobeNewswire, Inc.

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 13 May 2026 – Theon International Plc (THEON) is pleased to announce a $3 million strategic investment in Twin Prime, a US-based frontier AI lab building specialized models for defense and...

GlobeNewswire, Inc.

New Clinical Data Reinforce Proclarix® Performance in Reducing Overdiagnosis and Unnecessary Biopsies; Multi-Center PRIME Study Initiated in Collaboration with Labcorp; European Commercial Expansion Advances CINCINNATI, Ohio, May 13, 2026 (GLOBE...

GlobeNewswire, Inc.

New analyses show DLB patients with lower plasma pTau181 levels — indicating an earlier stage of disease and absence of Alzheimer’s disease (AD) co-pathology — experienced greater clinical benefit with neflamapimod in Phase 2b clinical trial PK/PD...

GlobeNewswire, Inc.

New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and 12 assays specific to brain and peripheral Tau isoforms...

GlobeNewswire, Inc.

CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused on completing development and enabling commercial access to stalled rare disease treatments, today announced that AGC...

GlobeNewswire, Inc.

DUBLIN and BRIDGEWATER, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced that additional REDUCE-IT patient...

GlobeNewswire, Inc.

NEWTON, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of...

Office of the California Governor

Through today’s historic visit, California and Catalonia reaffirm their partnership and recognize these milestones as an opportunity to deepen cooperation under the framework of the 2015 Memorandum of Understanding to: Collaborate to advance...

GlobeNewswire, Inc.

Tarrytown, New York, USA, March 18, 2026 (GLOBE NEWSWIRE) -- Research assays help generate evidence about whether biomarkers can advance disease management Novel RUO tests can help scientists understand neurological function and disease...

GlobeNewswire, Inc.

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 13 May 2026 – Theon International Plc (THEON) announces that its Annual General Meeting for the year 2026 (the AGM) will be held at the Amara Hotel, 95 Amathus Avenue, Agios Tychonas, 4533...

GlobeNewswire, Inc.

Fremont, CA, March 17, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of the NULISAseq Neuro 220 Panel with...

GlobeNewswire, Inc.

Utrecht, 12 March 2026 Aalberts N.V. announces the successful completion of regulatory approvals and closing conditions, finalising the divestment of BROEN A/S (Broen), headquartered in Denmark, generating an annual revenue of approximately EUR 82...

GlobeNewswire, Inc.

Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher Bio Follows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine release Commit is poised to nominate its first two clinical development candidates later...

GlobeNewswire, Inc.

Data further support choice of patient population and dosing regimen in CervoMed's planned Phase 3 trial in dementia with Lewy bodies (DLB) DLB is the second most common progressive dementia, affecting millions worldwide, and has no approved...